share_log

光大证券:关注合成生物学技术应用

Everbright Securities: Focus on the application of synthetic biology technology

Breakings ·  May 14 08:51
According to the Everbright Securities Research Report, it is recommended to focus on the application of synthetic biology technology. Recently, the concept of synthetic biology is popular. Synthetic biology uses engineering design concepts to transform or create artificial living systems or functional systems that surpass natural functions. Broadly speaking, it can be defined as a science and technology industry that uses bio-based materials to replace fossil-based materials and biotechnological routes to replace traditional chemical technology routes. Its application in the biomedical field is mainly in the two major directions of innovative drugs and innovative therapeutics, APIs, and pharmaceutical intermediates.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment